Triple-negative breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female patients aged 18-75 years; 2. The patients with clear pathological diagnosis of stage II - III triple-negative breast cancer agter operation; 3. The group completed from the completion of chemotherapy period was not more than 6 months, confirmed no recurrence or metastasis of the tumor; 4. The physical status(PS)ECOG score ranged from 0 to 2,the expeted survival >=6 months; 5. Agreed to participate in the study, informed consent.
Exclusion criteria
Exclusion criteria: 1. A serious disease of heart, liver, kidney and hematopoietic system; 2. Pregnant and lactating women; 3. Have a history of mental illness patients unable to cooperate; 4. Study on medication in patients with known hypersensitivity; 5. Patients were undergoing other drug test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease free survival;The rate of recurrence and metastasis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fatigue;Depression and anxiety; | — |
Countries
China
Contacts
Beijing University of Chinese Medicine,Beijing Chinese Medicine Hospital affiliate to Capital Medical University